Robert B M Landewe
Overview
Explore the profile of Robert B M Landewe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
4644
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van der Heijde D, Molto A, Ramiro S, Braun J, Dougados M, van Gaalen F, et al.
Ann Rheum Dis
. 2023 Dec;
83(5):547-549.
PMID: 38071514
Ankylosing spondylitis (AS) is the historic term used for decades for the HLA-B27-associated inflammatory disease affecting mainly the sacroiliac joints (SIJ) and spine. Classification criteria for AS have radiographic sacroiliitis...
12.
Janssen M, Landewe R, Post M, Erckens R, Mostard R
Curr Opin Pulm Med
. 2023 Jul;
29(5):485-492.
PMID: 37461850
Purpose Of Review: In recent years new recommendations have been published about organ assessment in the diagnosis of sarcoidosis. Recent Findings: Screening for pulmonary, cardiac, ocular, neurologic and renal involvement...
13.
Boone N, Moes D, Ramiro S, Mostard R, Magro-Checa C, van Dongen C, et al.
Br J Clin Pharmacol
. 2023 Feb;
PMID: 36791777
Aims: We aim to evaluate the clinical pharmacokinetics of a single dose interleukin-6 (IL-6) antibody tocilizumab (TCZ) in methylprednisolone (MP)-treated COVID-19 patients with cytokine storm syndrome (CSS). Methods: MP pre-treated...
14.
Combe B, Tanaka Y, Buch M, Nash P, Burmester G, Kivitz A, et al.
Rheumatol Ther
. 2023 Jan;
10(1):71-72.
PMID: 36598735
No abstract available.
15.
Wientjes M, Ulijn E, Kievit W, Landewe R, Meek I, den Broeder N, et al.
Rheumatology (Oxford)
. 2022 Dec;
62(8):2700-2706.
PMID: 36538875
Objectives: To quantify the additional value of a hypothetical biomarker predicting response to treatment for RA regarding efficacy and costs by using a modelling design. Methods: A Markov model was...
16.
Dejaco C, Landewe R
Rheumatology (Oxford)
. 2022 Dec;
62(8):2661-2664.
PMID: 36534821
Telemedicine is increasingly used in rheumatology. While telemedicine guaranteed care of patients during the COVID-19 pandemic, it is now increasingly used to facilitate triage of patients, monitoring of disease activity,...
17.
Bergstra S, Sepriano A, Kerschbaumer A, van der Heijde D, Caporali R, Edwards C, et al.
Ann Rheum Dis
. 2022 Nov;
82(1):81-94.
PMID: 36410794
This systematic literature review (SLR) regarding the efficacy, duration of use and safety of glucocorticoids (GCs), was performed to inform the 2022 update of the EULAR recommendations for the management...
18.
Sepriano A, Kerschbaumer A, Bergstra S, Smolen J, van der Heijde D, Caporali R, et al.
Ann Rheum Dis
. 2022 Nov;
82(1):107-118.
PMID: 36376026
Objectives: To perform a systematic literature review (SLR) concerning the safety of synthetic(s) and biological (b) disease-modifying antirheumatic drugs (DMARDs) to inform the 2022 update of the EULAR recommendations for...
19.
Kerschbaumer A, Sepriano A, Bergstra S, Smolen J, van der Heijde D, Caporali R, et al.
Ann Rheum Dis
. 2022 Nov;
82(1):95-106.
PMID: 36368906
Objectives: To update the evidence on efficacy of DMARDs (disease-modifying antirheumatic drugs) and inform the taskforce of the 2022 update of the European Alliance of Associations for Rheumatology (EULAR) recommendations...
20.
Smolen J, Landewe R, Bergstra S, Kerschbaumer A, Sepriano A, Aletaha D, et al.
Ann Rheum Dis
. 2022 Nov;
82(1):3-18.
PMID: 36357155
Objectives: To provide an update of the EULAR rheumatoid arthritis (RA) management recommendations addressing the most recent developments in the field. Methods: An international task force was formed and solicited...